Skip to content
Parakho

Windlas Biotech Ltd

NSE WINDLASBSE 543329windlas.com

Q1 FY27, unaudited

Revenue
₹248.10 Cr
Profit after tax
₹17.65 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations248.10+18.09%904.09
Other income5.11−2.41%17.80
Total income253.21+17.59%921.89
Employee benefit expense44.43+37.86%152.09
Finance costs1.65+56.10%4.83
Depreciation & amortisation7.21−3.25%30.74
Total expenses230.28+19.89%834.96
Profit before tax22.94−1.38%86.93
Tax expense5.28−5.54%20.50
Profit after tax17.65−0.07%66.44
Total comprehensive income17.61−0.53%66.55
Earnings per share
Earnings per share, basic₹8.46₹31.59
Earnings per share, diluted₹8.32₹31.14

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Windlas Biotech reported FY26 revenue of INR904 crores, up 19% year-on-year, with Q4 FY26 revenue at INR238 crores, up 18% year-on-year, marking 13 consecutive quarters of record revenue. Management attributed growth to the CDMO vertical, which grew 20% year-on-year, while the Trade Generics and Institutional vertical faced softness from the exit of codeine-based cough syrups. The company also reported completion of a buyback, a proposed dividend, and progress on Plant 6, which reached mechanical completion and is expected to commercialize in H1 FY27.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 50 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 14 Aug 2026.